Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03458247
Title Study of Dose Escalation of Abiraterone Actetate in Prostate Cancer (OPTIMABI)
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Assistance Publique - Hopitaux de Paris
Age Groups: adult | senior
Covered Countries FRA

No variant requirements are available.